Acarbose Reduces Myocardial Infarct Size by Preventing Postprandial Hyperglycemia and Hydroxyl Radical Production and Opening Mitochondrial KATP Channels in Rabbits-Reference-Cited by-同舟云学术

Acarbose Reduces Myocardial Infarct Size by Preventing Postprandial Hyperglycemia and Hydroxyl Radical Production and Opening Mitochondrial KATP Channels in Rabbits

Published:2009-07 Issue:1 Volume:54 Page:25-30
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Minatoguchi Shinya,Zhang Zengi,Bao Narentuoya,Kobayashi Hiroyuki,Yasuda Shinji,Iwasa Masamitsu,Sumi Syouhei,Kawamura Itta,Yamada Yoshihisa,Nishigaki Kazuhiko,Takemura Genzou,Fujiwara Takako,Fujiwara Hisayoshi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference22 articles.

1. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.;Stamler;Diabetes Care,1993

2. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS34).;Lancet,1998

3. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.;Tominaga;Diabetes Care,1999

4. Glucosidase inhibition. A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia.;Puls;Naturwissenschaften,1977

5. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial.;Chiasson;Lancet,2002

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial DNA Copy Number Is a Potential Biomarker for Treatment Choice Between Metformin and Acarbose;Clinical Pharmacology & Therapeutics;2023-03-20

2. AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases;Bioscience Reports;2019-02

3. Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset;Pathobiology of Aging & Age-related Diseases;2019-01-01

4. Pharmacological Preconditioning;Cardioprotection Against Acute Myocardial Infarction;2019

5. Interventions for age-related diseases: Shifting the paradigm;Mechanisms of Ageing and Development;2016-12